Chiron Real Estate Inc. (XRN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Chiron Real Estate Inc. stock (XRN) is currently trading at $34.33. Chiron Real Estate Inc. PS ratio (Price-to-Sales) is 6.31. Analyst consensus price target for XRN is $43.97. WallStSmart rates XRN as Sell.
- XRN PE ratio analysis and historical PE chart
- XRN PS ratio (Price-to-Sales) history and trend
- XRN intrinsic value — DCF, Graham Number, EPV models
- XRN stock price prediction 2025 2026 2027 2028 2029 2030
- XRN fair value vs current price
- XRN insider transactions and insider buying
- Is XRN undervalued or overvalued?
- Chiron Real Estate Inc. financial analysis — revenue, earnings, cash flow
- XRN Piotroski F-Score and Altman Z-Score
- XRN analyst price target and Smart Rating
Chiron Real Estate Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Chiron Real Estate Inc. (XRN) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, institutional own.. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Chiron Real Estate Inc. (XRN) Key Strengths (3)
Strong operational efficiency: $25 kept per $100 revenue
Trading at 1.18x book value, attractively priced
68.91% held by institutions, strong professional interest
Supporting Valuation Data
Chiron Real Estate Inc. (XRN) Areas to Watch (6)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Very expensive relative to growth, significant premium
Premium valuation at 6.3x annual revenue
Modest revenue growth at 9.20%
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Chiron Real Estate Inc. (XRN) Detailed Analysis Report
Overall Assessment
This company scores 39/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 8.0/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Operating Margin, Price/Book, Institutional Own.. Valuation metrics including Price/Book (1.18) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 25.10%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, PEG Ratio. Some valuation metrics including PEG Ratio (5.09), Price/Sales (6.31) suggest expensive pricing. Growth concerns include Revenue Growth at 9.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -1.27%, Profit Margin at -3.94%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -1.27% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 9.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
WallStSmart Analysis Synopsis
Data-driven financial summary for Chiron Real Estate Inc. (XRN) · REAL ESTATE › REIT - HEALTHCARE FACILITIES
The Big Picture
Chiron Real Estate Inc. is in a turnaround phase, with management focused on restoring profitability. Revenue reached 148M with 9% growth year-over-year. The company is currently unprofitable, posting a -394.0% profit margin.
Key Findings
Generating 18M in free cash flow and 22M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -394.0% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Dividend sustainability with a current yield of 9.8%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Chiron Real Estate Inc..
Bottom Line
Chiron Real Estate Inc. is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:29:08 AM
About Chiron Real Estate Inc.(XRN)
NYSE
REAL ESTATE
REIT - HEALTHCARE FACILITIES
USA
Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.